Patent ID: 9061040
Filing Date: 2015-06-23
Classification: A61K

Abstract:
1. A method for treatment of breast cancer in a human woman in need thereof, which comprises administering to said woman of 20 to 100 mg/day cyclophosphamide, 50 to 500 mg/day capecitabine (pentyl[1-(3,4-dihydroxy-5-methyl-tetrahydrofuran-2-yl)-5-fluoro-2-oxo-1H-pyrimidin-4-yl]aminomethanoate; Xeloda), 2 to 10 mg/day methotrexate, 20 to 500 mg/day N-(4-hydroxyphenyl) retinamide (Fenretinide), and 0.25 to 1.5 μg/day 1α,25-dihydroxyvitamin D3 (calcitriol).